Portfolio Finder

ADVANOVA was founded in January 2012 by Dr. Frank Hemer, a doctor and computer scientist, and Bastian Bleisinger, a computer scientist. The company’s head office is in Erlangen at the centre of Germany’s “Medical Valley”.

Avelios Medical offers a modular software platform for the digitization of workflows in hospitals and data-driven patient care. The state-of-the-art software digitizes and optimizes all workflows in hospitals in a user-friendly manner, offering numerous innovative functions such as an automatically generated doctor's letter or intelligent input fields for the documentation of patient treatment. In addition, the software automatically generates fully structured data, enabling the direct use of data-driven use cases and AI algorithms. The company is based in Munich and was founded in 2020 by Nicolas Jakob, Dr. Sebastian Krammer and Christian Albrecht.

C-mo Medical Solutions is an award-winning Digital Health start-up that develops solutions for the diagnosis and management of cough-incident medical conditions. The company’s mission is to unravel the clinical potential of cough assessment and solve the major unmet medical needs associated with the management of chronic cough. The company was founded by Diogo Tecelão, Miguel Andrade, Filipe Valadas, Alexandra Lopes, Sara Lobo, and Nuno Neuparth, thus combining a wealth of knowledge on digital health, business development, and respiratory medicine.

CereGate is developing a Computer-Brain-Interface (“BCI”) platform that is already capable to successfully submit information into the human brain. The revolutionary software platform is clinically validated and allows for enhanced treatment of various neurological and psychiatric disorders. The CereGate platform is able to transmit information into the brain („Mind-Writing“), by utilizing state of the art neuromodulation technology. While focusing first on improving gait symptoms for Parkinson patients, CereGate aims to become a key enabling tech¬nology in the field of rehabilitation and (neuro)prosthetics.

Hamburg-based COLIPI is developing an industrial biotechnological process that transforms climate-damaging CO2 and carbon-containing industrial waste into Climate Oil. This product serves as a sustainable and climate-neutral alternative to palm oil and crude oil. A patented bioreactor system is the key differentiator. The solution has the potential to become the world's fastest and, consequently, the most cost-effective CO2-transforming bioprocess. Some of the founders had initial exposure to the technology a decade ago. Since 2021, the project has been supported by EXIST, and in 2022, Philipp Arbeiter, Tyll Utesch, Jonas Heuer, and Maximilian Webers spun off COLIPI from the Technical University of Hamburg.

CorTec is a young medical engineering company focusing on innovations in the field of neurotechnology. With CorTec Brain Interchange we are developing a direct interface between brain and technology.

CustomSurg, founded in 2021, is a Spin-Off from ETH Zurich and Harvard University. The company is developing software-as-a-medical-device (SaMD) solutions for the optimal selection and placement of orthopaedic implants in the human body, thereby making surgery safer, faster, and simpler.

Ebenbuild is a health tech pioneer that creates personalized treatment recommendations for mechanical ventilation and ICU patient care for clinical users. Founded in Munich in 2019, the company develops software tools that generate precise patient-specific simulation models of lungs based on patient data, so-called digital twins of the lungs. These enable pinpoint individual medical decisions for intensive care patients with acute respiratory distress syndrome (ARDS). In this way, Ebenbuild aims to make a significant contribution to improving treatment as well as reducing mortality.

EEDEN starts upcycling – turning textile waste into valuable ressources for new fibres. The Company developed a chemical upcycling process for textile waste, recovering its resources. In this way, new, high-quality textiles can be created again from old textiles.
Globally textiles worth 100 bill. $ get landfilled or incinerated every year, while the industry faces resource shortages and regulatory pressure due to its ecological footprint. EEDENs product, a cellulose pulp for cellulosic fibres such as viscose or lyocell, is a solution to these problems.
The EEDEN team around the two founders, Reiner Mantsch and Steffen Gerlach, includes textile technologists, chemical engineers and chemists and will continue to grow in the coming months. Supported by consultants and a broad network to research and industry, the company is well prepared to further scale the EEDEN technology.

GWA Hygiene is committed to reducing the number of hospital infections. For this purpose, the company has developed NosoEx, a modern monitoring system for measuring hand hygiene. The IoT system can be seamlessly integrated into the infrastructure of the health facilities. For this purpose, the existing disinfectant dispensers are equipped with sensors. The software can then be used to see how the disinfection figures for each station, donor and occupational group are developing. Measures to improve the hygiene situation can then be initiated.
The Stralsund start-up was founded in 2015 and now has 25 employees. In addition to Maik Gronau and Tobias Gebhardt, Dirk Amtsberg, Marcel Walz and Daniel Neuendorf are among the founding partners. The NosoEx system is currently being used by a double-digit number of customers in Europe.
The NosoEx system is currently being used by a double-digit number of customers in the DACH region.

Hapila's counter-current crystallisation process provides a cost effective procedure for purification of active pharmaceutical ingredients, completed by experience in synthesis and particle design.

heartbeat ONE provides a streamlined patient management tool for health care facilities of all sizes. It offers intelligent evaluations of diagnostics and treatment methods. It supports the preparation, documentation and evaluation of medical interventions. Patient reported outcomes can automatically be collected for every patient. heartbeat ONE is hosted for customers in certified data centers in Germany or if desired self hosted on site.
Fully web-based the system heartbeat ONE runs on all major operating systems and requires only a modern browser. The integrated medical documentation has been enhanced by an algorithm that dynamically adapts to the treatment situation. In order to conduct patient surveys and a digital anamnesis via tablet at cite, native applications for iOS and Android platforms are available. Follow-up patient surveys are carried out over a separate patient portal which can be accessed from all devices (pc, smartphone, tablet, etc.).

iAtros is a digital heart clinic and a fully integrated platform, providing better medical care for patients with cardiovascular problems around the clock. Among other services, iATROS offers smart sensor diagnosis, a vital parameter data base, therapy- and medication regimes as well as teledoctor services.
Cardiologists Prof. Dr. med. Alexander Leber and Dr. med Georges von Degenfeld and eHealth entrepreneur Patrick Palacin founded iATROS in 2019. Former Sky executive and communications expert Prof Wolfram Winter and former AOK Berlin finance director Jens Schäfer are the co-founders.

neotiv is a spin-off of the Otto von Guericke University in the German city of Magdeburg in close collaboration with the Magdeburg site of the German Centre for Neurodegenerative Diseases (DZNE). neotiv incorporates the latest scientific findings from the fields of neuroscience and dementia research into mobile software that can be used on smartphones and tablets. Our work focuses on the development of a digital assistant that can monitor and aid users' memories and provide support for patients with dementia. neotiv is also designed to improve the early detection of Alzheimer's dementia and to facilitate efficacy monitoring for new therapies as they become available in the future. Biologically and anatomically valid and user-oriented measurements of specific memory functions, which can be carried out on a regular basis, form the core of the development of neotiv. The measurements focus on regions of the brain that are affected in the early stages of Alzheimer's disease. The vision behind neotiv is to (i) help reducing risk factors for cognitive decline by making lifestyle change simple and cognitive health measurable and (ii) to enable the innovative early detection of cognitive difficulties and dementia risk.

Nia Health is a spin-off of the Charité Universitätsmedizin Berlin. The start-up develops a clinical diagnosis and therapy system for the continuous digital support of patients with chronic skin conditions. With its platform, Nia Health addresses an often highly underserved patient population and generates treatment-relevant real world evidence. With its innovative machine vision approach, Nia Health enables accurate documentation of disease and therapy progression and thus optimised treatment. The company works closely with German patient associations and leading clinicians and has already won reputable customers from
the insurance and pharmaceutical industries. Amongst others, the Berlin-based company has developed the award-winning apps in the fields of atopic dermatitis (Nia) and psoriasis (Sorea), which were the first digital medical products of their kind to be approved worldwide. The digital medical solutions from Nia Health provide daily support for thousands of patients and their families.

Numaferm developed a platform technology for fast, scalable and cost-efficient production of peptides and proteins, with a focus on pepteins (PEPTides & protEINS) in the range of 30-500 amino acids. They serve customers from pharma, biotech, agriculture, and cosmetics offering peptides and proteins at highest qualities, within weeks, in a sustainable way. In this context partnership deals with global CDMO PolyPeptide and the world’s leading animal health company Zoetis were closed.
Founded in 2017 as a spin-out of Düsseldorf University, Numaferm has grown to over 20 staff.

PlastFormance develops, produces and markets unique polymer compounds for high-tech applications. The patented PlastFormance technology makes it possible to incorporate unprecedented amounts of ceramic and metallic fillers into a wide variety of plastics. PlastFormance materials differ fundamentally from competitor products in their unique combination of physical functionality (e.g. thermal conductivity or radiation protection), processability in injection molding and the use of spherical fillers. Prof. Dr. Dietmar Drummer, professor for plastics technology at the University of Erlangen-Nuremberg, supports the company as a scientific advisor.

PraxisEins is a state-supported practice network with the aim of solving the impending GP care vacuum. In order to avert the structural undersupply in large parts of the country, the practice network creates attractive jobs in poorly supplied regions and helps with its own software solutions for practice administration and patient communication.

Preventicus GmbH is developing smartphone-driven solutions to capture and analyze patients' vital parameters for early preclinical risk screening of lifestyle-related illnesses. Seed funding for the Jena-based company is managed by the German High-Tech Gründerfonds (HTGF) in Bonn and Born2Grow venture fund in Heilbronn. The capital is being provided to develop the products and portal to marketability.

RIMASYS offers prefractures specimen for educational purposes in the field of orthopedic surgery. The innovative MedTech company is setting new standards in surgical education and implant development through innovative education and validation with life-like fractured human specimen.

saperatec has developed an innovative technology to conserve and recover valuable and scarce materials through a recycling process. The firm initially plans to focus on photovoltaic modules and in the long term diversify its business into other areas. The innovative technology will in the long-term be adapted to other areas.

650 million people suffer from mental illness like depression, anxiety or burnout worldwide. Even in developed countries there is a huge treatment gap: 50% do not get treated. Selfapy offers scientifically proven online psychotherapy courses to make fast and affordable care accessible to everyone. Courses are effective at treating symptoms by combining advanced technology with elements of traditional care.

Sonormed is focused on digital medical products and builds the appropriate audiological infrastructure to adress the potential that large numbers of unserviced hearing damages, among them tinnitus, provide worldwide and to open up this market with new technologies.

WISE Srl is a Milan and Berlin-based company developing genuinely novel and minimally-invasive implantable leads for Neuromodulation and Neuromonitoring: highly conformable, stretchable, unbreakable and cheaper to produce.